Fasting stimulates 2-AG biosynthesis in the small intestine: Role of cholinergic pathways

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 309, Issue 8, 2015, Pages R805-R813

  Di Patrizio, Nicholas V ^a,b   Igarashi, Miki ^b   Narayanaswami, Vidya ^b   Murray, Conor ^b   Gancayco, Joseph ^b   Russell, Amy ^b   Jung, Kwang Mook ^b   Piomelli, Daniele ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

Cannabinoid receptor type 1 (CB1); Cholinergic receptor; Endocannabinoid; Gut brain; Vagus nerve

Indexed keywords

2 ARACHIDONOYLGLYCEROL; MESSENGER RNA; MONOACYLGLYCEROL; MUSCARINIC RECEPTOR; PEPTONE; PHOSPHOLIPASE C; PIRENZEPINE; SUCROSE; TETRAHYDROLIPSTATIN; ACYLGLYCEROL; AM6545; ARACHIDONIC ACID DERIVATIVE; ATROPINE; CANNABINOID 1 RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; ENDOCANNABINOID; ENZYME INHIBITOR; GLYCERYL 2-ARACHIDONATE; LACTONE; MORPHOLINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BODY WEIGHT; CHOLINERGIC SYSTEM; CHOLINERGIC TRANSMISSION; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; FOOD DEPRIVATION; FOOD INTAKE; HYDROLYSIS; JEJUNUM; LIQUID CHROMATOGRAPHY; MACRONUTRIENT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REFEEDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE; TANDEM MASS SPECTROMETRY; VAGOTOMY; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENETICS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ARACHIDONIC ACIDS; ATROPINE; ENDOCANNABINOIDS; ENZYME INHIBITORS; FOOD DEPRIVATION; GLYCERIDES; JEJUNUM; LACTONES; MALE; MORPHOLINES; PARASYMPATHOLYTICS; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1;

EID: 84944390743     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00239.2015     Document Type: Article

References (56)

1. Aaltonen N, Riera Ribas C, Lehtonen M, Savinainen JR, Laitinen JT. Brain regional cannabinoid CB1 receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase-deficient mice. Eur J Pharm Sci 51: 87-95, 2014.
2. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, Suda M, Koh T, Natsui K, Toyooka S, Shirakami G, Usui T, Shimatsu A, Doi K, Hosoda H, Kojima M, Kangawa K, Nakao K. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86: 4753-4758, 2001.
3. Astarita G, Piomelli D. Lipidomic analysis of endocannabinoid metabolism in biological samples. J Chromatogr B Analyt Technol Biomed Life Sci 877: 2755-2767, 2009.
4. Bellocchio L, Soria-Gomez E, Quarta C, Metna-Laurent M, Cardinal P, Binder E, Cannich A, Delamarre A, Haring M, Martin-Fontecha M, Vega D, Leste-Lasserre T, Bartsch D, Monory K, Lutz B, Chaouloff F, Pagotto U, Guzman M, Cota D, Marsicano G. Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade. Proc Natl Acad Sci USA 110: 4786-4791, 2013.
5. Berthoud HR. The vagus nerve, food intake and obesity. Regul Pept 149: 15-25, 2008.
6. Berthoud HR, Patterson LM, Zheng H. Vagal-enteric interface: vagal activation-induced expression of c-Fos and p-CREB in neurons of the upper gastrointestinal tract and pancreas. Anat Rec 262: 29-40, 2001.
7. Cluny NL, Vemuri VK, Chambers AP, Limebeer CL, Bedard H, Wood JT, Lutz B, Zimmer A, Parker LA, Makriyannis A, Sharkey KA. A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents. Br J Pharmacol 161: 629-642, 2011.
8. Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H, Kangawa K, Nakazato M. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123: 1120-1128, 2002.
9. DiPatrizio NV. Is fat taste ready for primetime? Physiol Behav 136: 145-154, 2014.
10. DiPatrizio NV, Astarita G, Schwartz G, Li X, Piomelli D. Endocannabinoid signal in the gut controls dietary fat intake. Proc Natl Acad Sci USA 108: 12904-12908, 2011.
11. DiPatrizio NV, Joslin A, Jung KM, Piomelli D. Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats. FASEB J 27: 2513-2520, 2013.
12. DiPatrizio NV, Piomelli D. Intestinal lipid-derived signals that sense dietary fat. J Clin Invest 125: 1-8, 2015.
13. DiPatrizio NV, Piomelli D. The thrifty lipids: endocannabinoids and the neural control of energy conservation. Trends Neurosci 35: 403-411, 2012.
14. Fu J, Astarita G, Gaetani S, Kim J, Cravatt BF, Mackie K, Piomelli D. Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine. J Biol Chem 282: 1518-1528, 2007.
15. Giuffrida A, Rodriguez de Fonseca F, Piomelli D. Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry. Anal Biochem 280: 87-93, 2000.
16. Gomez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I, Cippitelli A, Nava F, Piomelli D, Rodriguez de Fonseca F. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 22: 9612-9617, 2002.
17. Gregg LC, Jung KM, Spradley JM, Nyilas R, Suplita RL, Zimmer A, Watanabe M, Mackie K, Katona I, Piomelli D, Hohmann AG. Activation of type 5 metabotropic glutamate receptors and diacyl-glycerol lipase-alpha initiates 2-arachidonoylglycerol formation and endocannabinoid- mediated analgesia. J Neurosci 32: 9457-9468, 2012.
18. Grill HJ, Hayes MR. Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance. Cell Metab 16: 296-309, 2012.
19. Hao Z, Townsend RL, Mumphrey MB, Patterson LM, Ye J, Berthoud HR. Vagal innervation of intestine contributes to weight loss After Roux-en-Y gastric bypass surgery in rats. Obes Surg 24: 2145-2151, 2014.
20. Izzo AA, Piscitelli F, Capasso R, Aviello G, Romano B, Borrelli F, Petrosino S, Di Marzo V. Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. Br J Pharmacol 158: 451-461, 2009.
21. Jung KM, Astarita G, Zhu C, Wallace M, Mackie K, Piomelli D. A key role for diacylglycerol lipase-alpha in metabotropic glutamate receptordependent endocannabinoid mobilization. Mol Pharmacol 72: 612-621, 2007.
22. Jung KM, Sepers M, Henstridge CM, Lassalle O, Neuhofer D, Martin H, Ginger M, Frick A, DiPatrizio NV, Mackie K, Katona I, Piomelli D, Manzoni OJ. Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nat Commun 3: 1080, 2012.
23. Keen-Rhinehart E, Bartness TJ. Peripheral ghrelin injections stimulate food intake, foraging, and food hoarding in Siberian hamsters. Am J Physiol Regul Integr Comp Physiol 288: R716-R722, 2005.
24. Kim J, Isokawa M, Ledent C, Alger BE. Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J Neurosci 22: 10182-10191, 2002.
25. Lorenz D, Nardi P, Smith GP. Atropine methyl nitrate inhibits sham feeding in the rat. Pharmacol Biochem Behav 8: 405-407, 1978.
26. LoVerme J, Duranti A, Tontini A, Spadoni G, Mor M, Rivara S, Stella N, Xu C, Tarzia G, Piomelli D. Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice. Bioorg Med Chem Lett 19: 639-643, 2009.
27. Martin MB, Earle KR. Laparoscopic adjustable gastric banding with truncal vagotomy: any increased weight loss? Surg Endosc 25: 2522-2525, 2011.
28. Melis M, Perra S, Muntoni AL, Pillolla G, Lutz B, Marsicano G, Di Marzo V, Gessa GL, Pistis M. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. J Neurosci 24: 10707-10715, 2004.
29. Nakano I, Tawil T, Spannagel AW, Liddle RA, Green GM. Atropine enhances food-stimulated CCK secretion in the rat. Pancreas 5: 621-625, 1990.
30. Okafor PN, Lien C, Bairdain S, Simonson DC, Halperin F, Vernon AH, Linden BC, Lautz DB. Effect of vagotomy during Roux-en-Y gastric bypass surgery on weight loss outcomes. Obes Res Clin Pract 9: 274-280, 2015.
31. Piomelli D. More surprises lying ahead. The endocannabinoids keep us guessing. Neuropharmacology 76: 228-234, 2014.
32. Piomelli D, Astarita G, Rapaka R. A neuroscientist’s guide to lipidomics. Nat Rev Neurosci 8: 743-754, 2007.
33. Pradhan SN, Roth T. Comparative behavioral effects of several anticholinergic agents in rats. Psychopharmacologia 12: 358-366, 1968.
34. Przyborski SA, Levin RJ. Cholinergic modulation of electrogenic ion transport in different regions of the rat small intestine. J Pharm Pharmacol 49: 691-697, 1997.
35. Przyborski SA, Levin RJ. Enterocytes on rat jejunal villi but not in the crypts posses m3 mRNA for the M3 muscarinic receptor localized by in situ hybridization. Exp Physiol 78: 109-112, 1993.
36. Ramikie TS, Nyilas R, Bluett RJ, Gamble-George JC, Hartley ND, Mackie K, Watanabe M, Katona I, Patel S. Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses. Neuron 81: 1111-1125, 2014.
37. Randall PA, Vemuri VK, Segovia KN, Torres EF, Hosmer S, Nunes EJ, Santerre JL, Makriyannis A, Salamone JD. The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior. Pharmacol Biochem Behav 97: 179-184, 2010.
38. Rinaldo L, Hansel C. Muscarinic acetylcholine receptor activation blocks long-term potentiation at cerebellar parallel fiber-Purkinje cell synapses via cannabinoid signaling. Proc Natl Acad Sci USA 110: 11181-11186, 2013.
39. Romano JA, King JM. Conditioned taste aversion and cholinergic drugs: pharmacological antagonism. Pharmacol Biochem Behav 27: 81-85, 1987.
40. Schwartz GJ, Berkow G, McHugh PR, Moran TH. Gastric branch vagotomy blocks nutrient and cholecystokinin-induced suppression of gastric emptying. Am J Physiol Regul Integr Comp Physiol 264: R630-R637, 1993.
41. Senin LL, Al-Massadi O, Folguiera C, Pardo M, Barja-Fernandez S, Roca-Rivada A, Amil M, Criujeiras AB, Garcia-Caballero T, Gabellieri E, Leis R, Dieguez C, Pagotto U, Casanueva FF, Seoane LM. The gasric CB1 receptor modulates ghrelin production through the mTOR pathway to regulate food intake. PLoS One 8: e80339, 2013.
42. Shikora S, Toouli J, Herrera MF, Kulseng B, Zulewski H, Brancatisano R, Kow L, Pantoja JP, Johnsen G, Brancatisano A, Tweden KS, Knudson MB, Billington CJ. Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus. J Obes 2013: 245683, 2013.
43. Smith GP, Jerome C, Cushin BJ, Eterno R, Simansky KJ. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 213: 1036-1037, 1981.
44. Sohn JW, Harris LE, Berglund ED, Liu T, Vong L, Lowell BB, Balthasar N, Williams KW, Elmquist JK. Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons. Cell 152: 612-619, 2013.
45. Stadelmann AM, Walgenbach-Telford S, Telford GL, Koch TR. Distribution of muscarinic receptor subtypes in rat small intestine. J Surg Res 80: 320-325, 1998.
46. Stella N, Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388: 773-778, 1997.
47. Straiker A, Mackie K. Metabotropic suppression of excitation in murine autaptic hippocampal neurons. J Physiol 578: 773-785, 2007.
48. Sykaras AG, Demenis C, Case RM, McLaughlin JT, Smith CP. Duodenal enteroendocrine I-cells contain mRNA transcripts encoding key endocannabinoid and fatty acid receptors. PLoS One 7: e42373, 2012.
49. Tam J, Cinar R, Liu J, Godlewski G, Wesley D, Jourdan T, Szanda G, Mukhopadhyay B, Chedester L, Liow JS, Innis RB, Cheng K, Rice KC, Deschamps JR, Chorvat RJ, McElroy JF, Kunos G. Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance. Cell Metab 16: 167-179, 2012.
50. Tam J, Vemuri VK, Liu J, Batkai S, Mukhopadhyay B, Godlewski G, Osei-Hyiaman D, Ohnuma S, Ambudkar SV, Pickel J, Makriyannis A, Kunos G. Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. J Clin Invest 120: 2953-2966, 2010.
51. Vianna CR, Donato J Jr, Rossi J, Scott M, Economides K, Gautron L, Pierpont S, Elias CF, Elmquist JK. Cannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility. J Neurosci 32: 10331-10337, 2012.
52. Wang Y, Liu J. Combination of bypassing stomach and vagus dissection in high-fat diet-induced obese rats-a long-term investigation. Obes Surg 20: 375-379, 2010.
53. Williams KW, Elmquist JK. From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior. Nat Neurosci 15: 1350-1355, 2012.
54. Yamada M, Miyakawa T, Duttaroy A, Yamanaka A, Moriguchi T, Makita R, Ogawa M, Chou CJ, Xia B, Crawley JN, Felder CC, Deng CX, Wess J. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 410: 207-212, 2001.
55. Zhao Y, Tzounopoulos T. Physiological activation of cholinergic inputs controls associative synaptic plasticity via modulation of endocannabinoid signaling. J Neurosci 31: 3158-3168, 2011.
56. Zheng H, Berthoud HR. Functional vagal input to gastric myenteric plexus as assessed by vagal stimulation-induced Fos expression. Am J Physiol Gastrointest Liver Physiol 279: G73-G81, 2000.